InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,855.90
(
0.25%
)
US TECH 100
19,780.95
(
0.67%
)
Dow Jones
43,145.01
(
-0.22%
)
Brent Oil
72.72
(
-1.94%
)
Bitcoin
68,484.23
(
1.58%
)

Replies to post #229465 on Anavex Life Sciences Corp (AVXL)

Replies to #229465 on Anavex Life Sciences Corp (AVXL)
icon url

WolfofMia

01/09/20 10:58 AM

#229473 RE: frrol #229465

Apparently the OPC assay study with Biogen in early 2017 wasn't successful since there was no follow up in vivo remylenation study



Either that or the business relationship did not workout so they stopped all collaborations.

One is only left to speculate.
icon url

Gernee20

01/09/20 12:15 PM

#229500 RE: frrol #229465

Unless they did the OPC assay. We don't know they did not proceed. What we know is 2 years after the MTA was announced, Missling said the MTA was no longer in effect. I think 2 years is plenty of time to move forward with the OPC. One thing I am certain about, no deal to move into clinical trials would of taken place without a patent - and now we MS covered in yesterdays release.